Short stature is the most common endocrine disorder in children’s growth and development today, and is of great concern to children themselves, parents, teachers, and society. However, despite this, the consultation, diagnosis and treatment of short stature in children is always too late. Often, patients with dwarfism who are over 25 years old come to the doctor, and although their height can increase with treatment, it is impossible to reach the final average height of adults. Therefore, early detection, early diagnosis and early treatment of dwarfism are very important. The causes of short stature in children are divided into several categories, mainly children with short stature due to growth hormone deficiency and children with short stature due to non-growth hormone deficiency. Among the non-growth hormone deficiency diseases, there are familial short stature (genetic short stature of mothers and fathers), physical puberty delay (lack of puberty development or delayed puberty development leading to lifelong adult height failure), nutritional deficiency growth disorder, congenital ovarian hypoplasia (congenital short stature due to chromosomal defects in girls), and chondrodysplasia, which can cause growth disorders. All of the above conditions are indications for growth hormone treatment as confirmed by the FDA. The earlier the treatment, the better the outcome. The younger the age at which proper treatment begins, the better the outcome. Studies have shown that children with dwarfism caused by growth hormone deficiency can achieve nearly normal and rapid height growth with growth hormone treatment before the age of 3, and their final height is almost indistinguishable from that of a normal person. However, very few patients can start treatment at the age of 3 to 4 years old, and most patients come to the clinic only after puberty because they encounter setbacks in school, job assignment, military, marriage, etc. At this time, the treatment is effective, but far less effective than the treatment when they are young. The treatment of short stature is mainly selected according to different causes. The goals of treatment are: first, to maintain normal growth rate, second, to win rapid growth in adolescence, and third, to achieve final adult height. Growth hormone injections are the main method of treatment for short stature. The growth hormone currently used in clinical practice is genetically recombinant synthetic growth hormone, which is identical in structure and function to the growth hormone secreted by the human pituitary gland. However, the treatment of short stature with growth hormone is not a panacea. The best treatment is for complete or partial growth hormone deficiency, and those that may be effective are idiopathic short stature, Turner syndrome, familial short stature, etc. The medical community has been divided on whether growth hormone can be used to treat dwarfism, which is not a growth hormone deficiency. In recent years, several large clinical studies have found that children who are short but healthy and not deficient in growth hormone can increase their height by 3.8-7 cm by the time they reach adulthood with growth hormone injections. However, it is important to emphasize that growth hormone medication is intended for boys who are expected to be less than 160 cm tall in adulthood and girls who are less than 147 cm tall. During the period of growth hormone treatment, the efficacy of the treatment needs to be followed up every 3 months. Most people who are treated with growth hormone have an annual increase in height of 7 to 12 cm. If the expected growth does not occur, the reasons must be carefully analyzed, such as: intermittent treatment, poor preparation or injection technique, occurrence of hypothyroidism with systemic chronic diseases, epiphysis already closed, presence of excessive anti-growth hormone antibodies in the blood, short stature not due to growth hormone deficiency, untimely nutritional The number of patients with short stature was not increased in time. If these factors are found during the follow-up, they need to be addressed in a timely manner. Even if the child is growing well, thyroid function and bone age should be checked once a year. Currently, the percentage of children with abnormal dwarfism is about 1.2%, and about hundreds of thousands of children between the ages of 7 and 15 need active treatment. In conclusion, in general, those with taller parents, more adequate nutrition and more diligent physical activity have taller stature. However, all of these influences need to be based on physiological amounts of growth hormone. When the annual growth rate of children over 4 years old is found to be less than 4.5 cm, a growth hormone and epiphysis examination should be done, and if a deficiency is found, the earlier the supplemental treatment, the better, as supplemental growth hormone treatment after the age of 18 is three times less effective. May all parents in the world create good growth conditions for their children. Early diagnosis and treatment is important for short stature